T
Thomas Martin
Researcher at University of California, San Francisco
Publications - 311
Citations - 17918
Thomas Martin is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Medicine & Exocytosis. The author has an hindex of 73, co-authored 242 publications receiving 15771 citations. Previous affiliations of Thomas Martin include Institut national de la recherche agronomique & University of Western Australia.
Papers
More filters
Journal ArticleDOI
Bag3 Regulates Mitochondrial Function and the Inflammasome Through Canonical and Noncanonical Pathways in the Heart
Jufang Wang,Thomas Martin,Shubham Dubey,Praveen K Dubey,Jianliang Song,Gavin Landesberg,Michael G. McCormick,Valerie D. Myers,Salim Merali,Carmen Merali,Bonnie Lemster,Charles F. McTiernan,Kamel Khalili,Muniswamy Madesh,Joseph Y. Cheung,Jonathan A. Kirk,Arthur M. Feldman +16 more
Journal ArticleDOI
Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma.
Philippe Moreau,N. W. C. J. van de Donk,Hareth Nahi,Albert Oriol,Ajay K. Nooka,Thomas Martin,Laura Rosiñol,Lionel Karlin,Lotfi Benboubker,Maria-Victoria Mateos,Rakesh Popat,Joaquin Martinez-Lopez,Surbhi Sidana,Michel Delforge,Lixia Pei,D. Trancucci,Yunsi Olyslager,Clarissa M. Uhlar,Tara Stephenson,Rian Van Rampelbergh,Arnob Banerjee,Rachel Kobos,Saad Z. Usmani +22 more
TL;DR: The MajesTEC-1 trial as mentioned in this paper tested the cancer drug teclistamab in people with relapsed or refractory multiple myeloma, a cancer that forms in a certain type of white blood cells known as plasma cells.
Posted ContentDOI
Human Bone Marrow Plasma Cell Atlas: Maturation and Survival Pathways Unraveled by Single Cell Analyses
Meixue Duan,Doan C. Nguyen,Chester J. Joyner,Celia L. Saney,Christopher M. Tipton,Joel Andrews,Sagar Lonial,Caroline Kim,Ian Hentenaar,Astrid Kosters,Eliver Ghosn,Annette M. Jackson,Stuart J. Knechtle,Stalinraja Maruthamuthu,Sindhu Chandran,Thomas Martin,Raja Rajalingam,Flavio Vincenti,Cynthia A. Breeden,Ignacio Sanz,Greg Gibson,F. Eun-Hyung Lee +21 more
TL;DR: In this paper , a single cell resolution atlas and molecular roadmap of LLPC maturation was provided, which provides insight into differentiation trajectories and molecular regulation of these essential processes in the human BM microniche.
Journal ArticleDOI
EE167 Use of Cost per Responder Models for CAR-T Therapies in Relapsed or Refractory Multiple Myeloma
Thomas Martin,S. Usmani,Nedra Joseph,Concetta Crivera,SC Valluri,C. Jackson,L. Cohen,S Singh,Sundar Jagannath +8 more
TL;DR: In this article , the authors developed a cost per responder (CPR) model which incorporates efficacy and total treatment cost to evaluate the value of RRMM CAR-T therapies.
Journal ArticleDOI
Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study
Tadao Ishida,Shigeki Ito,Junji Tanaka,Michihiro Uchiyama,Yawara Kawano,Philippe Moreau,Thomas Martin,Marie-Laure Risse,K. Tada,Kenshi Suzuki,Kenichi Ishizawa +10 more
TL;DR: In this paper , an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.